GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION

被引：104

作者：

JACQZ, E ^{[1
]}

HALL, SD ^{[1
]}

BRANCH, RA ^{[1
]}

机构：

[1] VANDERBILT UNIV, MED CTR, SCH MED, DIV CLIN PHARMACOL, NASHVILLE, TN 37232 USA

来源：

HEPATOLOGY | 1986年 / 6卷 / 05期

关键词：

D O I：

10.1002/hep.1840060534

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：1020 / 1032

页数：13

相关论文

共 128 条

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS
ALDABBAGH, SG
IDLE, JR
SMITH, RL
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164
[2] RELATIONSHIP OF N-DEMETHYLATION OF AMIFLAMINE AND ITS METABOLITE TO DEBRISOQUINE HYDROXYLATION POLYMORPHISM
ALVAN, G
GRIND, M
GRAFFNER, C
SJOQVIST, F
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (04) : 515 - 519
[3] ALVAN G, 1982, LANCET, V1, P333
[4] INTERACTIONS BETWEEN NUTRITIONAL FACTORS AND DRUG BIOTRANSFORMATIONS IN MAN
ALVARES, AP
ANDERSON, KE
CONNEY, AH
KAPPAS, A
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) : 2501 - 2504
[5] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER
AYESH, R
IDLE, JR
RITCHIE, JC
CROTHERS, MJ
HETZEL, MR
[J]. NATURE, 1984, 312 (5990) : 169 - 170
[6] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[7] BERTILSSON L, 1982, JUL P SPS BPS
[8] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[9] GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES
BOOBIS, AR
MURRAY, S
HAMPDEN, CE
DAVIES, DS
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) : 65 - 71
[10] CAREY EL, 1981, CIRCULATION, V64, P264

← 1 2 3 4 5 6 7 8 9 10 →